Scientific Excellence and Clinical Innovationat the 2026 Hadassah Hematology Conference – RFHMO
Research Fund of the Hadassah Medical Organization (RFHMO) shared a post on LinkedIn:
“On February 12-13, 2026, the Hematology Division at Hadassah convened its annual Research Conference at the Dan Panorama Hotel in Tel Aviv – two intensive days dedicated to scientific excellence, clinical innovation, and interdisciplinary collaboration.
The conference reflected the division’s deep and sustained engagement in research across the full spectrum of hematology. The majority of presentations were conducted by physicians of the department and under their direct supervision, highlighting a strong culture of inquiry spanning basic, translational, and clinical research.
Scientific sessions addressed cutting-edge studies in multiple myeloma and amyloidosis, acute leukemias, lymphoma and CLL, MDS and MPN, coagulation and plasmapheresis, bone marrow transplantation and CAR-T therapies, as well as supportive and palliative medicine.
Annual updates summarized the latest international advances, reinforcing Hadassah’s position at the forefront of global hematologic research.
Beyond scientific depth, the conference emphasized the essential link between research and high-quality patient care. Active research does not exist in isolation, it directly translates into improved diagnostics, innovative therapies, and better clinical outcomes.
A dedicated session on medical education further underscored the division’s commitment to training the next generation of physician-scientists, strengthening Hadassah’s academic identity as a leader in clinical excellence, research innovation, and medical education.
At RFHMO, we are proud to support the research ecosystem that enables these achievements – fostering collaboration, empowering clinicians, and ensuring that scientific discovery continues to shape the future of hematologic care.
Follow RFHMO to stay connected with the research driving tomorrow’s medicine at Hadassah.”
Stay updated with Hemostasis Today.
-
Aug 19, 2026, 09:12Charlie Berman: Infections Following Mechanical Thrombectomy for Acute Stroke
-
Aug 19, 2026, 08:39Choosing the Right P2Y12 Inhibitor After PCI – JAMA Cardiology
-
Aug 19, 2026, 08:05Charles Cohen: Why Women Wait Years Longer for a Bleeding Disorder Diagnosis
-
Aug 19, 2026, 07:42Chukwuemeka Amarachi: Thalassemia – Types, Diagnosis and Management
-
Aug 19, 2026, 07:15Ajay Kumar: Real-World Outcomes of Plasma Exchange in NMOSD
-
Aug 19, 2026, 07:02Amer Zeidan: Managing Anemia in Lower-Risk MDS
-
Aug 19, 2026, 06:24GT Connect – Connecting the GT Community – Glanzmann’s Research Foundation
-
Aug 19, 2026, 01:43Elvira Grandone: Cancer and Thrombosis in Women – Where Do We Stand?
-
Aug 19, 2026, 01:37Ifeanyichukwu Ifechidere: Coagulation Knowledge – A Core Skill in Internal Medicine